Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company developing therapies for rare diseases with unmet medical needs, issued a sharehold ...

Given the number of times this has happened already, it should come as little surprise that we're now faced with yet another ...

The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections.

The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.

Additionally, SARS-CoV-2 variants of concern including delta and omicron show increased resistance to neutralizing antibodies, immune evasion, and transmissibility (13 – 18). Given the continued ...